US Biomax, Inc.

BR804

Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases/80 cores, replaced by BR804a

Microarray Panel:Breast tumor tissue microarray, containing 40cases of paired breast invasive cancer and matched normal adjacent tissue, single core per case
Cores:80
Cases:40
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Cytokeratin (Low-MW) confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Notes Image Type †
A1 1 F 38 Breast Infiltrating lobular carcinoma T3N1M0 Malignant
A2 2 F 38 Breast Cancer adjacent normal breast tissue of No. 01 NAT
A3 3 F 39 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N1M0 Malignant
A4 4 F 39 Breast Cancer adjacent normal breast tissue of No. 03 NAT
A5 5 F 38 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N1M0 Malignant
A6 6 F 38 Breast Cancer adjacent normal breast tissue of No. 05 NAT
A7 7 F 37 Breast Infiltrating lobular carcinoma T2N1M0 Malignant
A8 8 F 37 Breast Cancer adjacent normal breast tissue of No. 07 NAT
A9 9 F 36 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N3M3 Malignant
A10 10 F 36 Breast Cancer adjacent normal breast tissue of No. 09 NAT
B1 11 F 46 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N0M0 Malignant
B2 12 F 46 Breast Cancer adjacent normal breast tissue of No. 11 NAT
B3 13 F 42 Breast Cancer adjacent breast tissue T4N2M0 Malignant
B4 14 F 42 Breast Cancer adjacent normal breast tissue of No. 13 NAT
B5 15 F 53 Breast Fibrofatty tissue T3N1M1 Malignant
B6 16 F 53 Breast Cancer adjacent normal breast tissue of No. 15 NAT
B7 17 F 48 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II PT2N1M0 Malignant
B8 18 F 48 Breast Cancer adjacent normal breast tissue of No. 17 NAT
B9 19 F 78 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N1M0 Malignant
B10 20 F 78 Breast Cancer adjacent normal breast tissue of No. 19 NAT
C1 21 F 47 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N1M0 Malignant
C2 22 F 47 Breast Cancer adjacent normal breast tissue of No. 21 NAT
C3 23 F 45 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N2M0 Malignant
C4 24 F 45 Breast Cancer adjacent normal breast tissue of No. 23 NAT
C5 25 F 21 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II N/A Malignant
C6 26 F 21 Breast Cancer adjacent normal breast tissue of No. 25 N/A NAT
C7 27 F 30 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II PT2N1M0 Malignant
C8 28 F 30 Breast Fibrofatty tissue of No. 27 NAT
C9 29 F 38 Breast Tubular carcinoma T2N1M1 Malignant
C10 30 F 38 Breast Cancer adjacent normal breast tissue of No. 29 NAT
D1 31 F 34 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) III T4N2M0 Malignant
D2 32 F 34 Breast Cancer adjacent normal breast tissue of No. 31 NAT
D3 33 F 40 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) III T4N2M0 Malignant
D4 34 F 40 Breast Cancer adjacent normal breast tissue of No. 33 NAT
D5 35 F 52 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T4N2M0 Malignant
D6 36 F 52 Breast Cancer adjacent normal breast tissue of No. 35 NAT
D7 37 F 53 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) III T2N1M0 Malignant
D8 38 F 53 Breast Cancer adjacent normal breast tissue of No. 37 NAT
D9 39 F 51 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N0M0 Malignant
D10 40 F 51 Breast Cancer adjacent normal breast tissue of No. 39 NAT
E1 41 F 50 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) III N/A Malignant
E2 42 F 50 Breast Cancer adjacent normal breast tissue of No. 41 N/A NAT
E3 43 F 55 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N0M0 Malignant
E4 44 F 55 Breast Cancer adjacent normal breast tissue of No. 43 NAT
E5 45 F 37 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) III T3N1M0 Malignant
E6 46 F 37 Breast Cancer adjacent normal breast tissue of No. 45 NAT
E7 47 F 46 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T4N1M0 Malignant
E8 48 F 46 Breast Cancer adjacent normal breast tissue of No. 47 NAT
E9 49 F 81 Breast A little infiltrating ductal carcinoma not otherwise specified (NOS) PT4N1M0 Malignant
E10 50 F 81 Breast Fibrous tissue of No. 49 NAT
F1 51 F 52 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) I T2N2M0 Malignant
F2 52 F 52 Breast Cancer adjacent normal breast tissue of No. 51 NAT
F3 53 F 38 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) I T3N0M0 Malignant
F4 54 F 38 Breast Cancer adjacent normal breast tissue of No. 53 NAT
F5 55 F 43 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) III T2N1M0 Malignant
F6 56 F 43 Breast Cancer adjacent normal breast tissue of No. 55 NAT
F7 57 F 51 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T4N2M1 Malignant
F8 58 F 51 Breast Cancer adjacent normal breast tissue of No. 57 NAT
F9 59 F 32 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II PT4N0M0 Malignant
F10 60 F 32 Breast Cancer adjacent normal breast tissue of No. 59 NAT
G1 61 F 32 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N2M0 Malignant
G2 62 F 32 Breast Cancer adjacent breast tissue of No. 61 NAT
G3 63 F 30 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T4N0M0 Malignant
G4 64 F 30 Breast Cancer adjacent normal breast tissue of No. 63 NAT
G5 65 F 35 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N2M0 Malignant
G6 66 F 35 Breast Cancer adjacent normal breast tissue of No. 65 NAT
G7 67 F 49 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N2M0 Malignant
G8 68 F 49 Breast Cancer adjacent normal breast tissue of No. 67 NAT
G9 69 F 52 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N2M1 Malignant
G10 70 F 52 Breast Intraductal carcinoma of No. 69 NAT
H1 71 F 56 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N2M0 Malignant
H2 72 F 56 Breast Cancer adjacent breast tissue of No. 71 NAT
H3 73 F 40 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T2N2M1 Malignant
H4 74 F 40 Breast Cancer adjacent normal breast tissue of No. 73 NAT
H5 75 F 58 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II PT4NoM0 Malignant
H6 76 F 58 Breast Cancer adjacent normal breast tissue of No. 75 NAT
H7 77 F 36 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II T3N1M0 Malignant
H8 78 F 36 Breast Cancer adjacent normal breast tissue of No. 77 NAT
H9 79 F 35 Breast Infiltrating ductal carcinoma not otherwise specified (NOS) II PT2N1M0 Malignant
H10 80 F 356 Breast Cancer adjacent normal breast tissue of No. 79 NAT


"-" No grading available, *Tissue dots may be missing or histologically unidentifiable. † For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.


Find overlapping cases with this tissue array: